|
Hi there!
Good to see you again. Not much news on the developmental vaccine front. Nventa, the manufacturer of the HspE7 vaccine, is planning Phase II trials to see how well it works in treating precancerous cervical cell changes related to HPV. Still fairly early, then, in the process.
No update from the CIRCRVAX 6 study...last we head they were still processing the data, not sure exactly what that means. Everyone's eagerly awaiting the results, I can tell you.
Recurrences with warts can happen most anytime, most often within the first three months following treatment. While certainly possible, I don't think it's common for warts to return in someone who's been clear for six months or so.
Keep checking in and let us know how you are!
Best, Fredo
_________________ ASHA Moderator
|